Barclays PLC Has $5.89 Million Stake in Perrigo Company plc (NYSE:PRGO)

Barclays PLC lifted its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 90.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 228,908 shares of the company's stock after purchasing an additional 108,406 shares during the quarter. Barclays PLC owned about 0.17% of Perrigo worth $5,886,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Franklin Resources Inc. acquired a new stake in shares of Perrigo in the 3rd quarter worth approximately $3,717,000. JPMorgan Chase & Co. lifted its position in Perrigo by 65.1% in the third quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company's stock worth $14,190,000 after purchasing an additional 213,221 shares during the period. Virtu Financial LLC bought a new position in Perrigo during the 3rd quarter valued at $909,000. Access Investment Management LLC acquired a new position in shares of Perrigo during the 4th quarter valued at $7,989,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Perrigo by 1.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,048,005 shares of the company's stock worth $26,944,000 after buying an additional 13,835 shares in the last quarter. Institutional investors and hedge funds own 95.91% of the company's stock.

Perrigo Trading Down 0.9 %

Shares of PRGO traded down $0.23 during midday trading on Thursday, hitting $25.49. The stock had a trading volume of 194,690 shares, compared to its average volume of 1,521,970. Perrigo Company plc has a fifty-two week low of $23.14 and a fifty-two week high of $33.46. The business has a 50-day simple moving average of $26.55 and a two-hundred day simple moving average of $26.07. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. The firm has a market cap of $3.48 billion, a P/E ratio of -21.83 and a beta of 0.49.

Perrigo (NYSE:PRGO - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.01. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.20 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. As a group, equities analysts forecast that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 4.55%. Perrigo's dividend payout ratio is currently -92.80%.

Insider Buying and Selling

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the sale, the executive vice president now owns 33,666 shares of the company's stock, valued at $923,795.04. This trade represents a 18.81 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

PRGO has been the topic of several research reports. Argus cut shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Tuesday, January 14th. Piper Sandler downgraded shares of Perrigo from an "overweight" rating to a "neutral" rating and dropped their target price for the stock from $34.00 to $27.00 in a report on Monday, January 6th. Finally, StockNews.com cut shares of Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $33.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.